AlzeCure Pharma: FDA grants orphan drug designation for ACD440 - Redeye
Bildkälla: Stockfoto

AlzeCure Pharma: FDA grants orphan drug designation for ACD440 - Redeye

Redeye comments on the news that the FDA has granted ACD440 orphan drug designation (ODD) for the treatment of erythromelalgia.

Redeye comments on the news that the FDA has granted ACD440 orphan drug designation (ODD) for the treatment of erythromelalgia.
Börsvärldens nyhetsbrev